Folates are a group of essential micronutritional compounds that are found in bacteria and plants. Folic acid is a chemically synthesized, oxidized derivative that is converted to 5-methyltetrahydrofolate (5MTHF) by several enzymatic reactions. 5MTHF is the major biologically active form that functions as a cofactor in many methylation reactions. In particular, the conversion of homocysteine to methionine depends on 5MTHF. This reaction is required for the generation of S-adenosylmethionine (SAM) the central methyl-donor in most tissues and subcellular compartments. 5MTHF is distributed by the blood stream to all major organs where it can transverse cell membranes by at least three major transport systems 1 . The reduced folate carrier (RFC, SLC19A1) is an organic anion antiporter that exchanges 5MTHF with other inorganic or organic anions 2 . The influx Km of the RFC for 5MTHF and other reduced folates is 2-7 µM. The uptake of folates into enterocytes in the small intestine is mediated by the proton-coupled folate transporter (PCFT, SLC46A1). This transporter has a pH optimum of 5.5 and functions as proton cotransporter with a Km of about 1 µM 3 . Two glycosylphosphatidylinositol (GPI)-anchored receptors, folate receptor alpha (FRα) and beta (FR ), mediate endocytosis of folates after binding them with high affinity (Kb 1-10 nM) at neutral pH 4, 5 . The function of the secreted folate receptor gamma (FR ) and the very low affinity folate receptor delta (FR-δ) are currently not understood. In addition, several organic anion transporters (OAT) and ABC exporters (MRP1-5 and ABCG2)
are capable of transporting folates with low affinity 6, 7 .
We have recently described cerebral folate transport deficiency, a childhood neurodegenerative disease that is caused by mutations in the FOLR1 gene leading to a functional loss of FRα 8, 9 . Several other reports have confirmed the characteristics of this genetic disorder 10, 11 . Since the functional loss of FRα is associated with very low 5MTHF concentration in the CSF but normal plasma concentration of 5MTHF and since FRα is abundantly expressed in the choroid plexus, we have hypothesized that FRα provides the major route for blood-CSF transport of 5MTHF. In this study, we characterize the subcellular distribution of FRα and PCFT. We demonstrate that FRα mediates the transcellular 5MTHF transport into the CSF and that FRα-containing exosomes are targeted into the brain parenchyma.
RESULTS

Localization of FRα and PCFT in the human choroid plexus
To characterize the subcellular localization of FRα and PCFTin detail, an immunohistochemical analysis of sections of paraffin-embedded human choroid plexus specimens was performed. The detection with anti-human FRα antibody showed a polarized distribution of FRα, with strong staining at the apical brush border membrane and a minor
FRα-signal at the basolateral membrane of the choroid plexus epithelium (Fig. 1a) . The human PCFT was mainly detected in intracellular compartments (Fig. 1b) .
Immunofluorescence microscopy confirmed these results (Fig. 1c) .We substantiated the reported apical localization of the RFC in the human choroids plexus (Supplementary Fig.   S1a ). The preferential apical localization of FRα seem to contradict currently held views of the role of FRα in taking up 5MTHF at the basolateral side of the choroid plexus 12 . However, these findings substantiate published results obtained in mouse and rat brain sections 13, 14 as well as in human tissues 15 .
FRα and PCFT localize to intracellular vesicles in Z310 cells
We transfected the Z310 cell line derived from immortalized rat choroid plexus cells 16 with the human FRα, PCFT, RFC or vector, respectively, and detected their expression at high resolution. Both, FRα and PCFT were associated with intracellular vesicles that showed only marginal colocalization (Fig. 1d) . FRα-positive vesicles colocalize with late endosomal markers that are characteristic for multivesicular bodies (Fig. 1e) . Higher magnifications of multivesicular bodies by electron microscopy indicate the release of FRα-positive, intralumenal vesicles into the extracellular space (Fig. f,g,h) . PCFT-positive vesicles show an electron dense lumen and are not associated with multivesicular bodies (Fig. 1j,k) .
Basolateral to apical transport of FRα in polarized cells
We studied the transport of labelled folates in cultures of polarized cells and used the rat choroid plexus Z310 cells as a model system. Filter-grown Z310 cells, stably expressing FRα were incubated with FITC-labelled folic acid (FA-FITC). Anti-FRα antibody was added to the basolateral medium of the cells. Imaging of cells at various time points (0, 60 and 120 min) revealed FRα redistribution from the basolateral to the apical membrane (Fig. 2a-c) . In contrast, after apical labelling, no redistribution of FRα but a loss of fluorescence signal was observed, indicating unidirectional basolateral to apical transcytosis of FRα and release of FRα from the apical membrane ( Fig. 2d and e) .
To confirm the basolateral origin of the apically detected FRα protein, we removed FRα by the addition of phosphatidylinositol-specific phospholipase C (PI-PLC) to the basolateral medium. After incubation for 0, 60 and 120 min, FRα was released from the apical membrane by the addition of PI-PLC to the apical medium. Western blot analysis revealed a gradual reduction of FRα signal by maximal 76% after 120 min incubation ( Fig. 2f and g ).
This basolateral to apical cotransport of FRα together with FITC-labelled folic acid could be replicated in experiments with MDCK cells that were stably transfected with FRα ( Fig. 2h-n) .
However, in case of MDCK cells no significant reduction in apical fluorescence was observed after apical labelling and 120 min incubation ( Fig. 2k and l) . This suggests that in contrast to Z310 cells, MDCK cells do not release FRα from the apical surface.
We additionally analysed the distribution of FRα in HepG2 cells stably transfected with the human FOLR1 cDNA. FRα accumulated at the apical bile canalicular (BC) membrane and was less intensively expressed at the basolateral membrane (Supplementary Fig. S2a ). Fig. S2c ). These data support the notion of a vesicular transport of FRα from the basolateral to the apical membrane in polarized cells.
Blocking
Exosomal FRα expression correlates with 5MTHF in human CSF
To understand the mechanism of FRα shedding into the CSF, we fractionated human CSF by sequential centrifugation with increasing centrifugal forces. Surprisingly, FRα was enriched in the P100 (100.000 x g) fraction containing small vesicles with a diameter of 40 -100 nm and colocalizing with exosomal markers such as flotillin-2 (Flot-2) and Alix ( Fig. 3a-d ). Immunoelectron microscopy revealed the presence of FRα at the surface of exosomes, and two-color STED microscopy 17, 18 confirmed the vesicle-specific colocalization of FRα with the exosomal marker Alix ( Fig. 3c and d) . From the same STED data, the exact vesicle size could be assessed (Fig. 3e) and a quantitative colocalization of FRα with Alix was determined to be in the range of 36% ± 8%.
The importance of FRα release into the CSF was further investigated by Western blotting with human CSF from both healthy individuals and patients with cerebral folate transport deficiency. FRα could be detected in CSF of controls but was absent from patients that carry pathogenic FOLR1 mutations (Fig. 4a) Fig. S3 ).
For extended studies the radioactive medium was replaced with fresh medium after 1 h 
FRα released from choroids plexus cells is bound to exosomes
The vesicular nature of the directed FRα-dependent transport was confirmed by fractionation of the apical cell culture supernatant from FRα-transfected Z310 cells. FRα was enriched in the P100 (100.000 x g pellet) fraction and was co-purified with the exosomal markers Flot-2
and Alix (Fig. 5b) . The monensin-induced increase in FRα signal was proportional to the increase in Flot-2 and Alix release. Flot-2 and Alix release was also induced by monensin in vector-transfected cells in the absence of FRα. The vesicle-containing P100 fraction of FRα-transfected and monensin treated Z310 cells were subjected to sucrose gradient ultracentrifugation. Very similar to human CSF (Fig. 3b) Table S1 ).
The isolated vesicles showed the typical size of exosomes and could be co-stained for FRα and Alix in two-color STED microscopy ( Fig. 5d) . Quantitative analysis revealed a colocalization of 63% ± 8% of FRα and Alix. Incubation of PKH26-labelled FRα-positive and FRα-negative exosomes with FITC-labelled folic acid revealed specific colocalization of FITC-FA with FRα-positive exosomes (Fig. 5e ). These data demonstrate that exosomes We also compared the protein composition of exosome preparations derived from Z310 cells with the one purified from human CSF by mass spectrometry ( Table 1) .Both preparations contained 84-88% commonly accepted exosomal markers 22 and showed an overall similar protein profile.
To validate our findings in Z310 cells, we studied the directional 5MTHF transport in primary The supernatant of FRα-transfected MDCK cells (see Fig. 2h -n) were also fractionated but did not reveal any significant amount of vesicles in the P100 fraction and did not contain detectable exosomal markers or FRα. Correspondingly, no exosomal release of 5MTHF at the apical plasma membrane could be measured.
We performed additional experiments to evaluate FRα-independent transport processes in S4b ). Further, knocking-down endogenously expressed PCFT and RFC by specific siRNAs did not alter the FRα-mediated 5MTHF transport (Fig S4c,d ). These data indicate that at least at the physiological 5MTHF concentrations in plasma (4-20 nM), the major proportion of 5MTHF that is captured by FRα at the basolateral site of the choroid plexus is transcytosed and released from the apical border of the choroid plexus.
FRα-positive exosomes penetrate into brain parenchyma in vivo
We have unexpectedly discovered the release of FRα as exosomal cargo into the CSF. To further understand the biological function of this transport mechanism, we injected exosomes derived from FRα-transfected or vector-transfected Z310 cells into the lateral ventricle of C57BL/6 mice. Purified exosomes were labelled with the dye PKH26 before they were applied via stereotactically implanted intraventricular cannulas. Four hours post injection, the mice were euthanized and their brains immediately frozen. Immunohistochemistry of the mouse brain sections revealed that FRα-positive exosomes penetrated into the brain parenchyma distal from the injection site and colocalized with GFAP-positive astrocytes as well as NeuN-positive neurons ( Fig. 6a and b) . In contrast, FRα-negative exosomes were mainly detected close to the periventricular ependyma. No parenchymal staining was observed after injection of 100 nM FA-FITC into the mouse brain ventricles.
FRα-positive exosomes are internalized by astrocytes in vitro
To further confirm these in vivo findings, we incubated primary mixed cortical cultures obtained from neonatal mice with either PKH26-labelled exosomes, with FA-FITC or a combination of both. After incubating the cells for 2 hours at 37 °C, cells were fixed and analyzed by immunofluorescence microscopy. FRα-positive exosomes were selectively taken up by GFAP-postive astrocytes but no significant colocalization was obtained with cells stained with markers for microglia, neurons and oligodendrocytes (Fig. 6c) . FRα-negative exosomes did not colocalize with astrocytes but were internalized by Iba1-positive microglia.
FA-FITC was also delivered to astrocytes when combined with FRα-positive exosomes.
However, none of the cell types internalized 100 nM of free FA-FITC. . In addition, the occurrence of FRα autoantibodies in plasma is associated with low 5MTHF concentration in the CSF as well as with a similar neurodegenerative disease 24 . Our experiments with various polarized cells (MDCK, HepG2, Z310 cells) demonstrate a basolateral to apical sorting of FRα that provides for receptor-mediated endocytosis and transcytosis of folates ( Fig. 2 and S2 ). These findings indicate that the GPI-anchored FRα promote a vesicular transport of 5MTHF across the choroid plexus.
DISCUSSION
GPI-anchored proteins are known to be associated with specific subcellular compartments.
They enter the endosomal compartment by a clathrin-independent pathway to form tubular early endocytic compartments called GPI-anchored protein enriched endosomal compartments (GEECs) 25, 26 . Our data indicate FRα translocation to maturated endosomes that are named multivesicular bodies and that contain intralumenal vesicles. Multivesicular bodies are known to be sites for intracellular sorting of proteins between recycling, degradation and secretion pathways 27 . We have provided several lines of evidence that in choroid plexus cells FRα-containing multivesicular bodies fuse with the apical membrane and secrete their intralumenal vesicles as exosomes ( Fig. 1e-h, Fig. 7) . We further suggest that
FRα recycles between the apical membrane and the late endosomal compartment and thus offers 5MTHF uptake from the CSF as well. The absence of effect in folate binding and transport after transfection of human PCFT and human RFC or after siRNA-suppression of endogenous rat PCFT and rat RFC indicates the essential role of FRα-mediated transport of 5MTHF at its physiological concentration ( Supplementary Fig. S5b-d) . Further, the pharmacological inhibition of various folate transporters did not alter folate binding to Z310 choroid plexus cells (Supplementary Fig. S4 ). These results are consistent with recent studies on primary rat choroid plexus epithelial cells that show two separate folate uptake mechanisms 28 . One FRα-dependent process mediates efficient uptake of 5MTHF at low extracellular folate concentrations. The other uptake mechanism is independent of FRα but likely depends on organic transporters such as the RFC and accounts for folate uptake at higher concentrations. It is possible that in case of abundant folate supply 5MTHF may follow other routes of internalization and transport in the choroid plexus. However, it is likely that any free 5MTHF released into the CSF will be picked up by membrane attached FRα either present on exosomes or on the apical surface of the choroid plexus. Since about 36% of all human CSF exosomes contain FRα (Fig. 3d) and since brain FRα exclusively origins from the choroid plexus 8 we consider the human choroid plexus as a major source of CSF exosomes.
Our data indicate that human PCFT is localized to intracellular vesicles that are distinct from but may marginally colocalize with FRα-positive intralumenal vesicles (Fig. 1d,j,k) . Our The unusual cargo transport mechanism of 5MTHF might serve as a stabilizing and buffering system for fluctuations in folate supply and demand of the brain. Most excitingly, our results indicate that exosome targeting into the brain parenchyma crucially depends on the expression of FRα (Fig. 6) . Though the molecular mechanism of this selective uptake is presently not clear we hypothesize that FRα induces a signal for exosome internalization. 
Human samples
All CSF samples were immediately shock frozen after lumbar puncture and stored at -80°C.
CSF samples recruited from patients suffering from cerebral folate transport deficiency that were recently characterized in detail 9 . CSF samples from nine patients with genetically confirmed Kearns-Sayre-syndrome (KSS) were analyzed. The KSS patients, six female and three male individuals, were aged between 11 and 25 years at the time of the lumbar puncture. CSF samples from five individuals with suspected hydrocephalus or idiopathic intracranial hypertension, three males and two females that were aged between two and 16 years were used as controls. Paraffin sections of human choroid plexus from post-mortem autopsy blocks were retrieved from the Department of Neuropathology, University of Goettingen. Informed consent was obtained from the patients or parents and the study was approved by the ethical review board of the medical faculty of the University of Goettingen.
Cell cultures and transfections
Z310 cells were grown in DMEM supplemented with 10% fetal calf serum, 10 ng/mL epidermal growth factor (Invitrogen) and antibiotics. Madin-Darby canine kidney (MDCK) cells were maintained MEM supplemented with 10% fetal calf serum and antibiotics. The human polarized hepatic cell line HepG2 was grown in RPMI 1640 medium supplemented with 10% fetal calf serum and antibiotics. All cells were incubated at 37°C in 5% CO 2 .
Transfections were done using Effectene transfection reagent (Qiagen) and stable transfectants were selected in the presence of the appropriate antibiotics.
Porcine choroid plexus epithelial cells (PCPECs) were prepared basically as described 
Transcytosis assays
Transcytosis assays were adapted from Polishchuk et al.
39
.
Before the experiments, cells
were maintained in folate-free RPMI 1640 medium. Filter-grown Z310 or MDCK cells stably expressing FRα incubated on ice for 15 min with 100 nM FA-FITC together with anti-human FRα antibody (Mov18/ZEL) added to the basolateral chamber of the transwell plate. Some filters were fixed immediately after incubation on ice, while others were shifted to 37°C for the indicated time points, fixed and prepared for confocal microscopy. Biochemical evaluation of transcytosis was based on the idea that removal of protein from the basolateral surface will result in decrease of its amount at the apical domain of the plasma membrane 40 . Therefore, filter-grown Z310 or MDCK cells stable expressing FRα were incubated with PI-PLC added to the basolateral medium for the indicated time points. To detect the apical portion of FRα, cells were washed and PI-PLC was added to the apical medium 30 min on ice to harvest the receptor from the apical domain of the plasma membrane. Samples were than subjected to Western blotting.
Exosome preparation
Exosomes were prepared from human CSF or from cell culture supernatant by performing sequential centrifugation. Therefore CSF or supernatant from Z310 cells was centrifuged for 15 min at 1500 x g to remove debris. The supernatant was then subjected to ultracentrifugation at 10.000 x g for 45 min and at 100.000 x g for 150 min. The collected pellets were finally resuspended in CellLytic™M Cell Lysis Reagent (Sigma) and subjected to Western blotting. For further analysis, the exosome samples were layered on top of a sucrose gradient and centrifuged for 16 hours at 100.000 x g. Subsequently, fractions were collected, diluted 1:4 in PBS and centrifuged at 100.000 x g for 70 min. Pellets were resuspended in Laemmli sample buffer and subjected to Western blotting. For immunofluorescence analysis, the exosome pellet was resuspended in PBS and stained with PKH26 (Sigma).
Electron microscopy
Exosomes were fixed with 4% paraformaldehyde and absorbed to glow discharged formvarcarbon coated copper grids. The samples were immunolabelled with anti-human FRα antibody (Mov18/ZEL) or anti-human Flotillin-2 antibody followed by a rabbit anti-mouse antibody. The antibodies were detected with Protein A coupled to 10 nm gold particles. After contrasting by neutral uranyl acetate, samples were imaged on a Leo EM912AB-electron microscope (Zeiss) and images were acquired using on axis 2048X2048 charge-coupled device camera (Proscan, Schering). Z310 cells were treated with 7 µM monensin for 4 hours.
Cells were then fixed and prepared for postembedding immunohistochemistry according to 41 .
Immunofluorescence microscopy and image analysis
Confocal images were acquired on a spinning disk confocal imaging system (UltraView®, Perkin-Elmer). The system incorporated an Olympus IX81 inverted microscope using a 100X 
High-resolution stimulated emission depletion microscopy
Exosomes were directly fixed on glass coverslips with 4% paraformaldehyde. Two-color stimulated emission depletion (STED) microscopy was performed as previously described 18 , using sheep anti-mouse polyclonal antibody labelled with Atto590 (for anti-human FRα as first antibody) and goat anti-rabbit polyclonal antibody conjugated to Atto647N (for Alix as marker for exosomes). The colocalization of FRα and Alix was analyzed by using the "colocalization threshold" algorithm from ImageJ.
Mass spectrometry analysis
Exosomes were prepared as described above and the exosome pellet was directly denatured in Laemmli sample buffer containing 50 mM dithiothreitol (DTT) for 10 min at 70°C. Mass spectrometry was then conducted as described previously 42 . Semiquantitative analysis of the relative exosomal protein abundance was determined by the ranking of unweighted spectrum counts with the program Scaffold 3.
FRα-mediated 5MTHF uptake and transport analysis
For 5MTHF uptake and transport measurements in Z310 cells, 4. 
Immunohistochemistry of choroid plexus
Immunohistochemistry was carried out as previously described 43 . Staining on human sections was performed using mouse monoclonal FRα antibody (NCL-L-FRalpha) or rabbit polyclonal PCFT antibody followed by HRP-conjugated secondary antibodies. After development, the slides were counterstained with hematoxylin. For immunofluorescence, the sections were treated as described above except the use of secondary Alexa 488 donkey anti-mouse or Alexa 546 donkey anti rabbit antibodies.
Internalization assay
Mixed cortical cultures were obtained from neonatal mice and immediately plated on coverslips and incubated in the respective growth medium. Before the internalization assay, exosomes were purified from Z310 cells, stably transfected with FRα or vector and labelled with PKH26 and FA-FITC as described above. The uptake was performed by incubating the cell cultures with exosome dilutions for 2 hours at 37°C and 5% CO 2 . Cells were then fixed, permeabilized and stained with the respective antibodies for immunofluorescence analysis.
In vivo experiments were carried out with C57BL/6 mice at the ages between 80 days and 100 days. The mice were anesthetized with ketamine (100-125 mg/kg) and xylazine (10-12,5 mg/mL) and the intraventricular cannulas were stereotaxically implanted into the lateral ventricle as described previously 44 . 10 µL of labelled exosome solution were injected into the intraventricular cannula 4 hours before the mice were euthanized. Intact brains were then dissected, immediately frozen in liquid nitrogen pre-cooled isopentane and stored at -20°C.
For fluorescence analysis, the frozen brain tissues were cryosectioned to a thickness of 10 µm. The frozen sections were fixed in 4% paraformaldehyde for 30 min at room temperature.
After washing in PBS, sections were blocked for 1 hour in PBS containing 10% (w/v) horse serum and 0.2% BSA. Antibodies against GFAP and NeuN were applied overnight in carrier containing 1% horse serum and 0.2% BSA in PBS. After washing with PBS, slides were incubated with appropriate secondary Alex488 antibodies for 2 hours. After washing in PBS sections were embedded in ProLong Gold with DAPI (Invitrogen). Images were acquired with a confocal microscope (Olympus FV1000).
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